ArticleInternational journal of molecular sciences2013

Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.

Peter S Kirk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.